Latest updates for Abbv

Fresh curated links around ABBV are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst
  • AbbVie: Upside Potential And Dividends With Competent Portfolio Renewal
  • Abbott forecasts 6.5%-7.5% 2026 comparable sales growth while integrating Exact Sciences with $0.20 EPS dilution

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 day ago

Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst

Read source
seekingalpha.com /1 month ago

AbbVie: Upside Potential And Dividends With Competent Portfolio Renewal

Read source
seekingalpha.com /1 month ago

Abbott forecasts 6.5%-7.5% 2026 comparable sales growth while integrating Exact Sciences with $0.20 EPS dilution

Read source
cafepharma.com /2 days ago

May 28 2026 - AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer

May 28 2026 - AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer admin Thu, 05/28/2026 - 11:51 Steady progress across the board today, with new appro...

Read source
seekingalpha.com /2 weeks ago

Alfen N.V. (ABHBY) Q1 2026 Earnings Call Transcript

Read source
cafepharma.com /1 month ago

AbbVie Oncology

AbbVie Oncology Anonymous (not verified) Tue, 04/07/2026 - 20:01 field_thread_url https://cafepharma.com/boards/threads/abbvie-oncology.699564/...

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement]]>

Read source
finance.yahoo.com /5 days ago

Two Paths to Growth: Johnson & Johnson vs AbbVie

Read source
fiercebiotech.com /3 weeks ago

Avalo’s phase 2 skin disease win fuels pursuit of AbbVie despite placebo headwind

The placebo-adjusted result fell short of the bar set by Avalo, analysts and AbbVie’s rival program, but the biotech’s stock jumped in premarket trading.

Read source
cafepharma.com /1 month ago

MSLs at Abbvie

MSLs at Abbvie Anonymous (not verified) Wed, 04/29/2026 - 14:17 field_thread_url https://cafepharma.com/boards/threads/msls-at-abbvie.668170/...

Read source
pharmexec.com /1 month ago

<![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]>

Read source
seekingalpha.com /1 month ago

Abbott ordered to pay $70M in damages in Chicago baby formula case

Read source
fool.com /1 month ago

Why AbbVie Is a No-Brainer Stock to Buy on the Dip

The pharma giant is still a rock-solid dividend stock.

Read source
agriland.ie /4 weeks ago

ABP announces acquisition of German beef processing facility

The ABP Food Group has today (Friday, May 1) announced the acquisition – by its affiliated entity ABP GmbH – of Vion Food Group’s beef processing facility in Germany. The acquisiti...

Read source
seekingalpha.com /1 month ago

Assembly Biosciences, Inc. (ASMB) Presents at ESCMID Global 2026 - Slideshow

Read source
fiercebiotech.com /1 month ago

Abbott lowers EPS guidance on Exact Sciences buy as shares slide

Abbott's first-quarter numbers reflect is operational complexity.

Read source
benzinga.com /1 month ago

Abbott Labs Annual Guidance Cut Overshadows Earnings Beat, Stock Cracks

Abbott cuts 2026 earnings outlook despite Q1 beat; medical devices strength offset by weaker diagnostics demand and nutrition sales decline. Importance Rank: ...

Read source
pharmexec.com /1 month ago

<![CDATA[AbbVie Invests $1.4 Billion into New Manufacturing Campus in North Carolina ]]>

Read source
seekingalpha.com /1 month ago

Abbott Laboratories: Buying A Healthcare Giant On Sale

Read source
seekingalpha.com /1 month ago

AB Dynamics plc 2026 Q2 - Results - Earnings Call Presentation

Read source
medcitynews.com /2 days ago

AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer

AbbVie drug Decnupaz received FDA approval for treating blastic plasmacytoid dendritic cell neoplasm, or BPDCN. This antibody drug conjugate came from AbbVie’s 2023 ImmunoGen acqui...

Read source
fool.com /6 days ago

What's the Better Dividend Stock Today: AbbVie or Pfizer?

These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.

Read source
fool.com /6 days ago

What's the Better Dividend Stock Today: AbbVie or Pfizer?

These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.

Read source
finance.yahoo.com /1 month ago

Abbott Laboratories Q1 2026 Earnings Call Summary

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Abbv

feeds.benzinga.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source